Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
VOL 2 No. 4 Full Issue - April 2000
1
x
$
20.00
Psychopharmacology Bulletin VOL 47 No. 1, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Risperidone: Review of Its Therapeutic Utility in Depression
1
x
$
30.00
A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae
1
x
$
30.00
Psychopharmacotherapy in Eating Disorders: A Systematic Analysis
1
x
$
30.00
Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)
1
x
$
0.00
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
A Comprehensive Review and Update of the Use of Dexmedetomidine for Regional Blocks
1
x
$
30.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
View Cart
Checkout
Home
second-generation-antipsychotics
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Metabolic Syndrome among Patients Taking Atypical Antipsychotics: A Comparative Cross-Sectional Study at Erada and Mental Health Complex in Taif, Saudi Arabia
$
30.00
Add to cart
Details
Off-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
$
30.00
Add to cart
Details
Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
$
30.00
Add to cart
Details
Ross A. Baker – Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
$
30.00
Add to cart
Details
Page load link
Go to Top
